PHILADELPHIA, May 9, 2023 /PRNewswire/ — Interius BioTherapeutics, a preclinical stage gene therapy company developing novel methods for…
News + Press
Explore by Category
Select
Interius BioTherapeutics Announces Successful Manufacturing Partnership with WuXi Advanced Therapies
May 09, 2023
Interius BioTherapeutics Announces Successful Manufacturing Partnership with WuXi Advanced Therapies
May 09, 2023
PHILADELPHIA, May 9, 2023 /PRNewswire/ — Interius BioTherapeutics, a preclinical stage gene therapy company developing novel methods for…
Interius BioTherapeutics Hosts Immersive, Hands-on Event to Ignite Students’ Passion for Science
April 27, 2023
Philadelphia, PA – April 27, 2023 – Interius BioTherapeutics, a preclinical stage gene therapy company…
Interius’ Senior Director of Analytical Development to Speak at 14th Annual Bioprocessing Summit
November 01, 2022
An innovation showcase of protein degraders, RNA therapeutics, delivery vectors and gene modifiers
The BrightEdge Fund 2021 Annual Review
November 01, 2022
An innovation showcase of protein degraders, RNA therapeutics, delivery vectors and gene modifiers
Interius Named as Finalist for the Deal of the Year Award by Life Sciences Pennsylvania
November 01, 2022
An innovation showcase of protein degraders, RNA therapeutics, delivery vectors and gene modifiers
BioCentury’s 2021 Class of Emerging Companies
February 14, 2022
An innovation showcase of protein degraders, RNA therapeutics, delivery vectors and gene modifiers
Interius Bio Announces Granting of US Patent to Support in Vivo Cell-Specific Gene Delivery Platform
December 09, 2021
Company also celebrates “Deal of the Year” awarded by The Penn Center for Innovation PHILADELPHIA,…
Pennovation Lab Welcomes New Tenant Interius BioTherapeutics to Its Innovation Ecosystem
October 05, 2021
page 1 of 2